XTX Topco Ltd Takes $469,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

XTX Topco Ltd purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, HoldingsChannel reports. The firm purchased 3,549 shares of the financial services provider’s stock, valued at approximately $469,000.

Several other large investors also recently added to or reduced their stakes in IBB. Westside Investment Management Inc. lifted its holdings in shares of iShares Biotechnology ETF by 1.2% in the 3rd quarter. Westside Investment Management Inc. now owns 17,002 shares of the financial services provider’s stock worth $2,477,000 after acquiring an additional 204 shares during the last quarter. Tudor Financial Inc. purchased a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $405,000. Sculati Wealth Management LLC grew its stake in shares of iShares Biotechnology ETF by 21.0% during the third quarter. Sculati Wealth Management LLC now owns 11,530 shares of the financial services provider’s stock valued at $1,582,000 after buying an additional 2,004 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in shares of iShares Biotechnology ETF in the third quarter worth approximately $263,000. Finally, Franklin Resources Inc. lifted its stake in shares of iShares Biotechnology ETF by 3.3% during the 3rd quarter. Franklin Resources Inc. now owns 18,285 shares of the financial services provider’s stock worth $2,664,000 after acquiring an additional 580 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 0.4 %

Shares of iShares Biotechnology ETF stock opened at $118.29 on Monday. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $150.57. The company has a market capitalization of $5.29 billion, a PE ratio of 24.21 and a beta of 0.84. The stock’s fifty day moving average is $129.81 and its two-hundred day moving average is $135.71.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were paid a $0.1212 dividend. The ex-dividend date was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.